Nov 17, 2020 Cerecor to Collaborate with Frontiers CDG Consortium on Pivotal Trial of CERC-801 for the Treatment of PGM1-CDG
Aug 26, 2020 Cerecor Resumes Phase 1b Clinical Trial of CERC-002 for the Treatment of Severe Pediatric Onset Crohn’s Disease
Aug 13, 2020 Cerecor Announces Peer-Reviewed Publication Highlighting the Role of the Inflammatory Cytokine, LIGHT, in COVID-19 ARDS
Aug 4, 2020 Cerecor Receives Rare Pediatric Disease Designation for CERC-006 in Lymphatic Malformations